Last $26.51 USD
Change Today -0.36 / -1.34%
Volume 170.2K
QDEL On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

quidel corp (QDEL) Snapshot

Open
$26.91
Previous Close
$26.87
Day High
$27.01
Day Low
$26.28
52 Week High
01/15/14 - $32.24
52 Week Low
04/24/14 - $19.21
Market Cap
909.5M
Average Volume 10 Days
206.6K
EPS TTM
$-0.31
Shares Outstanding
34.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for QUIDEL CORP (QDEL)

Related News

No related news articles were found.

quidel corp (QDEL) Related Businessweek News

No Related Businessweek News Found

quidel corp (QDEL) Details

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women’s health, and gastrointestinal diseases. The company offers Sofia analyzer, a fluorescent immunoassay system for hospitals, medical centers, and small clinics; various molecular assays, which run on thermocyclers; Sofia influenza A+B and QuickVue influenza tests for the detection of the viral antigens of influenza type A and B; and Sofia strep A fluorescent immunoassay and QuickVue Strep A tests for the detection of group A Streptococcal antigen from throat swabs. It also provides Sofia RSV and QuickVue RSV tests for respiratory syncytial virus; cell culture and DFA detection solutions for the detection of various viral respiratory pathogens; and various traditional cell lines, specimen collection devices, media, and controls for the use in laboratories. In addition, the company offers ELVIS HSV, a cell culture system for the isolation and detection of herpes simplex virus types 1 and 2; and multiplex cell culture solution. Further, it provides Quidel Molecular Direct clostridium difficile assay; Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests, which are used for the detection of hCG in serum or urine for the early detection of pregnancy; Thyretain for the differential diagnosis of Graves disease; and QuickVue Chlamydia test for the detection of Chlamydia trachomatis. Additionally, the company offers QuickVue test, a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; serological test that measures antibodies circulating in the blood; and diagnostic and research products for oncology, bone health, and autoimmune diseases. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

572 Employees
Last Reported Date: 02/27/14
Founded in 1979

quidel corp (QDEL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $509.1K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $313.2K
Senior Vice President of Commercial Operation...
Total Annual Compensation: $307.0K
Senior Vice President of Clinical & Regulator...
Total Annual Compensation: $297.5K
Senior Vice President of Business Development...
Total Annual Compensation: $329.0K
Compensation as of Fiscal Year 2013.

quidel corp (QDEL) Key Developments

Quidel Receives FDA Clearance for its Hand-Held Molecular Diagnostic Test for Group A Strep

Quidel Corporation announced that it has received clearance from the United States Food and Drug Administration (FDA) to market its AmpliVue GAS Assay for the qualitative detection of Group A -hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens obtained from patients with signs and symptoms of pharyngitis, such as sore throat.

Quidel Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Tax Rate Guidance for the Full Year 2014

Quidel Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenues of $31.488 million compared to $29.706 million a year ago. The increase in revenue was due to greater sales of Infectious Disease products, as well as growth in all other product segments. Operating loss was $9.985 million compared to $6.953 million a year ago. Loss before income tax was $10.357 million compared to $7.312 million a year ago. Net loss was $6.908 million or $0.20 per basic and diluted share compared to $1.755 million or $0.05 per basic and diluted share a year ago. Adjusted net loss was $3.426 million or $0.10 per share compared to $1.893 million or $0.06 per share a year ago. In the quarter, the company used $4.9 million in cash for operating activities and incurred $2.7 million in capital expenditures. For the six months, the company reported total revenues of $78.161 million compared to $91.701 million a year ago. The decrease in revenue was primarily driven by softer demand for Infectious Disease products in the first quarter due to a weaker respiratory disease season in 2014, relative to the same period in 2013. Operating loss was $12.002 million compared to operating income of $10.402 million a year ago. Loss before income tax was $12.733 million compared to income before income tax of $9.679 million a year ago. Net loss was $8.420 million or $0.25 per diluted share compared to net income of $10.612 million or $0.30 per diluted share a year ago. Adjusted net loss was $0.491 million or $0.01 per share compared to adjusted net income of $14.660 million or $0.42 per share a year ago. For the full year 2014, the company estimates tax rate of 34%.

Quidel Corp. to Report Q2, 2014 Results on Jul 22, 2014

Quidel Corp. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Jul 22, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QDEL:US $26.51 USD -0.36

QDEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analogic Corp $65.20 USD +1.24
Ion Beam Applications €14.00 EUR 0.00
Luminex Corp $19.80 USD +0.30
OraSure Technologies Inc $7.04 USD -0.18
Volcano Corp $10.29 USD -0.35
View Industry Companies
 

Industry Analysis

QDEL

Industry Average

Valuation QDEL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.8x
Price/Book 4.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUIDEL CORP, please visit www.quidel.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.